Management of Menopausal Symptoms: A Review
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Importance: Menopause, due to loss of ovarian follicular activity without another pathological or physiological cause, typically occurs between the ages of 45 years and 56 years. During the menopausal transition, approximately 50% to 75% of women have hot flashes, night sweats, or both (vasomotor symptoms) and more than 50% have genitourinary symptoms (genitourinary syndrome of menopause [GSM]). Observations: Vasomotor symptoms typically last more than 7 years and GSM is often chronic. Efficacious treatments for women with bothersome vasomotor symptoms or GSM symptoms include hormonal and nonhormonal options. Systemic estrogen alone or combined with a progestogen reduces the frequency of vasomotor symptoms by approximately 75%. Oral and transdermal estrogen have similar efficacy. Conjugated equine estrogens (CEE) with or without medroxyprogesterone acetate (MPA) were the only hormonal treatments for which clinical trials were designed to examine cardiovascular events, venous thromboembolism, and breast cancer risk. Compared with placebo, the increased risk of stroke and venous thromboembolism associated with CEE (with or without MPA) and breast cancer (with use of CEE plus MPA) is approximately 1 excess event/1000 person-years. Low-dose CEE plus bazedoxifene is not associated with increased risk of breast cancer (0.25%/year vs 0.23%/year with placebo). Bioidentical estrogens approved by the US Food and Drug Administration (with identical chemical structure to naturally produced estrogens, and often administered transdermally) also are available to treat vasomotor symptoms. For women who are not candidates for hormonal treatments, nonhormonal approaches such as citalopram, desvenlafaxine, escitalopram, gabapentin, paroxetine, and venlafaxine are available and are associated with a reduction in frequency of vasomotor symptoms by approximately 40% to 65%. Low-dose vaginal estrogen is associated with subjective improvement in GSM symptom severity by approximately 60% to 80%, with improvement in severity by 40% to 80% for vaginal prasterone, and with improvement in severity by 30% to 50% for oral ospemifene. Conclusions and Relevance: During the menopausal transition, approximately 50% to 75% of women have vasomotor symptoms and GSM symptoms. Hormonal therapy with estrogen is the first-line therapy for bothersome vasomotor symptoms and GSM symptoms, but nonhormonal medications (such as paroxetine and venlafaxine) also can be effective. Hormone therapy is not indicated for the prevention of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
Self-citationManson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Self-citationHarlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., de Villiers, T. J., & for the STRAW + 10 Collaborative Group (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3362 · Cited by 1,325
Cauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,221
Wassertheil-Smoller, S., Hendrix, S., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., Kotchen, T., Curb, J. D., Black, H., Rossouw, J. E., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2673 · Cited by 1,159
Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition
Avis, N. E., Crawford, S. L., Greendale, G., Bromberger, J. T., Everson-Rose, S. A., Gold, E. B., Hess, R., Joffe, H., Kravitz, H. M., Tepper, P. G., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.8063 · Cited by 1,028
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
Self-citationGold, E. B., Colvin, A., Avis, N., Bromberger, J., Greendale, G. A., Powell, L., Sternfeld, B., & Matthews, K. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.066936 · Cited by 932
Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 930
Self-citationTreatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Espeland, M. A. (2004) · JAMA · doi:10.1001/jama.291.24.2959 · Cited by 795
Vascular effects of early versus late postmenopausal treatment with estradiol
Hodis, H. N., Mack, W. J., Henderson, V. W., Shoupe, D., Budoff, M. J., Hwang-Levine, J., Li, Y., Feng, M., Dustin, L., Kono, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505241 · Cited by 779
Portman, D. J., & Gass, M. L. S. (2014) · Menopause · doi:10.1097/gme.0000000000000329 · Cited by 688
Qaseem, A., Forciea, M. A., McLean, R. M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m15-1361 · Cited by 676
Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups
Avis, N. E., Stellato, R., Crawford, S., Bromberger, J., Ganz, P., Cain, V., & Kagawa-Singer, M. (2001) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00147-7 · Cited by 643
Manson, J. E., Aragaki, A. K., Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Chlebowski, R. T., Howard, B. V., Thomson, C. A., Margolis, K. L., et al. (2017) · JAMA · doi:10.1001/jama.2017.11217 · Cited by 638
Self-citationEstrogen plus progestin and risk of venous thrombosis
Cushman, M. (2004) · JAMA · doi:10.1001/jama.292.13.1573 · Cited by 632
Local oestrogen for vaginal atrophy in postmenopausal women
Lethaby, A., Ayeleke, R. O., & Roberts, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub3 · Cited by 601
Long-term health consequences of premature or early menopause and considerations for management
Faubion, S. S., Kuhle, C. L., Shuster, L. T., & Rocca, W. A. (2015) · Climacteric · doi:10.3109/13697137.2015.1020484 · Cited by 544
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
MacLennan, A. H., Broadbent, J. L., Lester, S., & Moore, V. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002978.pub2 · Cited by 543
LaCroix, A. Z. (2011) · JAMA · doi:10.1001/jama.2011.382 · Cited by 538
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
Sullivan, S. D., Sarrel, P. M., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.046 · Cited by 505
Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C. S., Brinton, E. A., Cedars, M. I., Lobo, R. A., Merriam, G. R., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001833 · Cited by 490
Self-citationIncreased cardiovascular mortality after early bilateral oophorectomy
Rivera, C. M., Grossardt, B. R., Rhodes, D. J., Brown, R. D., Roger, V. L., Melton, L. J., & Rocca, W. A. (2009) · Menopause · doi:10.1097/gme.0b013e31818888f7 · Cited by 481
Bromberger, J. T., Kravitz, H. M., Chang, Y.-F., Cyranowski, J. M., Brown, C., & Matthews, K. A. (2011) · Psychological Medicine · doi:10.1017/s003329171100016x · Cited by 439
Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019) · BMJ · doi:10.1136/bmj.k4810 · Cited by 433
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Heiss, G. (2008) · JAMA · doi:10.1001/jama.299.9.1036 · Cited by 396
Forgive and Remember: Managing Medical Failure
Anderson, J. G. (2004) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.291.14.1775 · Cited by 362
Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative
Hendrix, S. L., Wassertheil-Smoller, S., Johnson, K. C., Howard, B. V., Kooperberg, C., Rossouw, J. E., Trevisan, M., Aragaki, A., Baird, A. E., Bray, P. F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594077 · Cited by 359
Utian, W. H., Shoupe, D., Bachmann, G., Pinkerton, J. V., & Pickar, J. H. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01791-5 · Cited by 348
Harman, S. M., Black, D. M., Naftolin, F., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hopkins, P. N., Lobo, R. A., Manson, J. E., Merriam, G. R., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0353 · Cited by 344
Self-citationPandya, K. J., Raubertas, R. F., Flynn, P. J., Hynes, H. E., Rosenbluth, R. J., Kirshner, J. J., Pierce, H. I., Dragalin, V., & Morrow, G. R. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-10-200005160-00004 · Cited by 310
Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.
Goldberg, R. M., Loprinzi, C. L., O'Fallon, J. R., Veeder, M. H., Miser, A. W., Mailliard, J. A., Michalak, J. C., Dose, A. M., Rowland, K. M., & Burnham, N. L. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.155 · Cited by 292
Phytoestrogens for menopausal vasomotor symptoms
Lethaby, A., Marjoribanks, J., Kronenberg, F., Roberts, H., Eden, J., & Brown, J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001395.pub4 · Cited by 287
Lobo, R. A., Pinkerton, J. V., Gass, M. L. S., Dorin, M. H., Ronkin, S., Pickar, J. H., & Constantine, G. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.113 · Cited by 254
Labrie, F., Archer, D. F., Koltun, W., Vachon, A., Young, D., Frenette, L., Portman, D., Montesino, M., Côté, I., Parent, J., et al. (2016) · Menopause · doi:10.1097/gme.0000000000000571 · Cited by 246
Efficacy of Escitalopram for Hot Flashes in Healthy Menopausal Women: A Randomized Controlled Trial
Freeman, E. W. (2011) · JAMA · doi:10.1001/jama.2010.2016 · Cited by 245
Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis
Henderson, V. W., St. John, J. A., Hodis, H. N., McCleary, C. A., Stanczyk, F. Z., Shoupe, D., Kono, N., Dustin, L., Allayee, H., & Mack, W. J. (2016) · Neurology · doi:10.1212/wnl.0000000000002980 · Cited by 242
Beerepoot, M. A. J. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.777 · Cited by 240
Jackson, R. D., Wactawski-Wende, J., LaCroix, A. Z., Pettinger, M., Yood, R. A., Watts, N. B., Robbins, J. A., Lewis, C. E., Beresford, S. A., Ko, M. G., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060312 · Cited by 239
Bachmann, G. A., & Komi, J. O. (2010) · Menopause · doi:10.1097/gme.0b013e3181c1ac01 · Cited by 235
Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause
Prentice, R. L., Manson, J. E., Langer, R. D., Anderson, G. L., Pettinger, M., Jackson, R. D., Johnson, K. C., Kuller, L. H., Lane, D. S., Wactawski-Wende, J., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp115 · Cited by 234
Self-citationEvans, M. L., Pritts, E., Vittinghoff, E., McClish, K., Morgan, K. S., & Jaffe, R. B. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000147840.06947.46 · Cited by 231
Espeland, M. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.7727 · Cited by 226
Exercise for vasomotor menopausal symptoms
Daley, A., Stokes-Lampard, H., Thomas, A., & MacArthur, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006108.pub4 · Cited by 225
Stearns, V., Slack, R., Greep, N., Henry-Tilman, R., Osborne, M., Bunnell, C., Ullmer, L., Gallagher, A., Cullen, J., Gehan, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.081 · Cited by 224
Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus
Curb, J. D., Prentice, R. L., Bray, P. F., Langer, R. D., Van Horn, L., Barnabei, V. M., Bloch, M. J., Cyr, M. G., Gass, M., Lepine, L., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.772 · Cited by 217
Joffe, H., Guthrie, K. A., LaCroix, A. Z., Reed, S. D., Ensrud, K. E., Manson, J. E., Newton, K. M., Freeman, E. W., Anderson, G. L., Larson, J. C., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1891 · Cited by 191
Self-citationMcCurry, S. M., Guthrie, K. A., Morin, C. M., Woods, N. F., Landis, C. A., Ensrud, K. E., Larson, J. C., Joffe, H., Cohen, L. S., Hunt, J. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1795 · Cited by 189
Mitchell, C. M., Reed, S. D., Diem, S., Larson, J. C., Newton, K. M., Ensrud, K. E., LaCroix, A. Z., Caan, B., & Guthrie, K. A. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.0116 · Cited by 188
Pinkerton, J. V., Utian, W. H., Constantine, G. D., Olivier, S., & Pickar, J. H. (2009) · Menopause · doi:10.1097/gme.0b013e3181a7df0d · Cited by 184
The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?
Miller, V. M., Naftolin, F., Asthana, S., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Dowling, N. M., Gleason, C. E., Hodis, H. N., et al. (2019) · Menopause · doi:10.1097/gme.0000000000001326 · Cited by 182
Self-citationAcupuncture for menopausal hot flushes
Dodin, S., Blanchet, C., Marc, I., Ernst, E., Wu, T., Vaillancourt, C., Paquette, J., & Maunsell, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007410.pub2 · Cited by 178
Huang, A. J., Gregorich, S. E., Kuppermann, M., Nakagawa, S., Eeden, S. K. V. D., Brown, J. S., Richter, H. E., Walter, L. C., Thom, D. H., & Stewart, A. L. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000281 · Cited by 163
Zhu, D., Chung, H.-F., Pandeya, N., Dobson, A. J., Kuh, D., Crawford, S. L., Gold, E. B., Avis, N. E., Giles, G. G., Bruinsma, F., et al. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-018-0367-y · Cited by 158
Hodis, H. N., Mack, W. J., Shoupe, D., Azen, S. P., Stanczyk, F. Z., Hwang-Levine, J., Budoff, M. J., & Henderson, V. W. (2015) · Menopause · doi:10.1097/gme.0000000000000343 · Cited by 152
SSRIs for Hot Flashes: A Systematic Review and Meta-Analysis of Randomized Trials
Shams, T. M., Firwana, B., Habib, F., Alshahrani, A., AlNouh, B., Murad, M. H., & Ferwana, M. S. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2535-9 · Cited by 151
Long, C.-Y., Liu, C.-M., Hsu, S.-C., Wu, C.-H., Wang, C.-L., & Tsai, E.-M. (2006) · Menopause · doi:10.1097/01.gme.0000227401.98933.0b · Cited by 142
Simon, J. A., Lin, V. H., Radovich, C., & Bachmann, G. A. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31826d36ba · Cited by 138
Miller, V. M., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hodis, H. N., Lobo, R. A., Manson, J. E., Merriam, G. R., Naftolin, F., et al. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9104-y · Cited by 136
Self-citationHormone replacement therapy in young women with surgical primary ovarian insufficiency
Sarrel, P. M., Sullivan, S. D., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.018 · Cited by 133
The Menopause Transition and Cognition
Greendale, G. A., Karlamangla, A. S., & Maki, P. M. (2020) · JAMA · doi:10.1001/jama.2020.1757 · Cited by 131
Gordhandas, S., Norquist, B. M., Pennington, K. P., Yung, R. L., Laya, M. B., & Swisher, E. M. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.12.014 · Cited by 128
SHUFELT, C. L., & Manson, J. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab042 · Cited by 128
Self-citationLabrie, F., Archer, D. F., Koltun, W. D., Vachon, A., Young, D. G., Frenette, L., Portman, D. J., Montesino, M., Côté, I., Parent, J., et al. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001238 · Cited by 126
Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally
Bachmann, G., Bouchard, C., Hoppe, D., Ranganath, R., Altomare, C., Vieweg, A., Graepel, J., & Helzner, E. (2009) · Menopause · doi:10.1097/gme.0b013e3181a48c4e · Cited by 124
Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction
Santoro, N. F., Worsley, R., Miller, K. K., Parish, S. J., & Davis, S. R. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.11.015 · Cited by 124
US Preventive Services Task Force, Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M. D., Caughey, A. B., Chelmow, D. P., Coker, T. R., Davis, E. M., Donahue, K. E., et al. (2022) · JAMA · doi:10.1001/jama.2022.18625 · Cited by 123
Greendale, G. A., Espeland, M., Slone, S., Marcus, R., & Barrett-Connor, E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.6.665 · Cited by 122
Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women
Freeman, E. W., Sammel, M. D., Gross, S. A., & Pien, G. W. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000392 · Cited by 121
Sarri, G., Pedder, H., Dias, S., Guo, Y., & Lumsden, M. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14619 · Cited by 113
Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review
Goldštajn, M. Š., Mikuš, M., Ferrari, F. A., Bosco, M., Uccella, S., Noventa, M., Török, P., Terzic, S., Laganà, A. S., & Garzon, S. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06647-5 · Cited by 111
Marchetti, C., Felice, F. D., Boccia, S. M., Sassu, C. M., Donato, V. D., Perniola, G., Palaia, I., Monti, M., Muzii, L., Tombolini, V., et al. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.09.018 · Cited by 108
Raz, R., Colodner, R., Rohana, Y., Battino, S., Rottensterich, E., Wasser, I., & Stamm, W. E. (2003) · Clinical Infectious Diseases · doi:10.1086/374341 · Cited by 107
Archer, D. F., Labrie, F., Bouchard, C., Portman, D. J., Koltun, W., Cusan, L., Labrie, C., Côté, I., Lavoie, L., Martel, C., et al. (2015) · Menopause · doi:10.1097/gme.0000000000000428 · Cited by 107
Prentice, R. L., Aragaki, A. K., Chlebowski, R. T., Rossouw, J. E., Anderson, G. L., Stefanick, M. L., Wactawski‐Wende, J., Kuller, L. H., Wallace, R. B., Johnson, K., et al. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa210 · Cited by 94
Self-citationPortman, D. J., Labrie, F., Archer, D. F., Bouchard, C., Cusan, L., Girard, G., Ayotte, N., Koltun, W., Blouin, F., Young, D., et al. (2015) · Menopause · doi:10.1097/gme.0000000000000470 · Cited by 93
Clinical trial of the estradiol vaginal ring in the U.S.
Nachtigall, L. E. (1995) · Maturitas · doi:10.1016/0378-5122(95)00963-9 · Cited by 86
Black cohosh (Cimicifuga spp.) for menopausal symptoms
Leach, M., & Moore, V. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007244 · Cited by 81
Joffe, H., Crawford, S., Economou, N., Kim, S., Regan, S., Hall, J. E., & White, D. (2013) · Sleep · doi:10.5665/sleep.3244 · Cited by 79
Chen, Y., Su, T.-H., & Lau, H. (2020) · International Urogynecology Journal · doi:10.1007/s00192-020-04397-z · Cited by 78
Handley, A. P., & Williams, M. (2014) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12137 · Cited by 77
Anderson, D. J., Chung, H., Seib, C. A., Dobson, A. J., Kuh, D. J., Brunner, E. J., Crawford, S. L., Avis, N. E., Gold, E. B., Greendale, G. A., et al. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.10.103 · Cited by 76
Menopause versus chronologic aging: their roles in women's health
Thurston, R. C., Karvonen-Gutierrez, C. A., Derby, C. A., Khoudary, S. R. E., Kravitz, H. M., & Manson, J. E. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001143 · Cited by 73
Self-citationMartel, C., Labrie, F., Archer, D. F., Ke, Y., Gonthier, R., Simard, J.-N., Lavoie, L., Vaillancourt, M., Montesino, M., Balser, J., et al. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.016 · Cited by 72
Kravitz, H. M., Janssen, I., Bromberger, J. T., Matthews, K. A., Hall, M. H., Ruppert, K., & Joffe, H. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0084-1 · Cited by 72
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms
Guthrie, K. A., LaCroix, A. Z., Ensrud, K. E., Joffe, H., Newton, K. M., Reed, S. D., Caan, B. J., Carpenter, J. S., Cohen, L. S., Freeman, E. W., et al. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000927 · Cited by 67
Self-citationPinkerton, J. V., Shifren, J. L., Valleur, J. L., Rosen, A. S., Roesinger, M., & Siddhanti, S. R. (2003) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200310010-00008 · Cited by 66
Archer, D., FURST, K., TIPPING, D., DAIN, M.-P., & VANDEPOL, C. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00359-2 · Cited by 66
Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy
Holmgren, P.-Å., Lindskog, M., & von Schoultz, B. (1989) · Maturitas · doi:10.1016/0378-5122(89)90120-5 · Cited by 63
Simon, J. A., Portman, D. J., & Mabey, R. G. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.12.005 · Cited by 63
Manson, J. E., Aragaki, A. K., Bassuk, S. S., Chlebowski, R. T., Anderson, G. L., Rossouw, J. E., Howard, B. V., Thomson, C. A., Stefanick, M. L., Kaunitz, A. M., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0274 · Cited by 62
Self-citationCritical appraisal of paroxetine for the treatment of vasomotor symptoms
Carroll, D. G., Lisenby, K. M., & Carter, T. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s50804 · Cited by 60
Swica, Y., Warren, M. P., Manson, J. E., Aragaki, A. K., Bassuk, S. S., Shimbo, D., Kaunitz, A. M., Rossouw, J. E., Stefanick, M. L., & Womack, C. R. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001067 · Cited by 55
Self-citationShan, D., Zou, L., Liu, X., Shen, Y., Cai, Y., & Zhang, J. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.12.011 · Cited by 55
Relaxation for perimenopausal and postmenopausal symptoms
Saensak, S., Vutyavanich, T., Somboonporn, W., & Srisurapanont, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008582.pub2 · Cited by 53
Dueñas-García, O. F., Sullivan, G., Hall, C. D., Flynn, M. K., & O’Dell, K. K. (2016) · Urogynecology · doi:10.1097/spv.0000000000000244 · Cited by 53
Endometrial safety of ospemifene: results of the phase 2/3 clinical development program
Constantine, G. D., Goldstein, S. R., & Archer, D. F. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000275 · Cited by 51
Effect of escitalopram on hot flash interference: a randomized, controlled trial
Carpenter, J. S., Guthrie, K. A., Larson, J. C., Freeman, E. W., Joffe, H., Reed, S. D., Ensrud, K. E., & LaCroix, A. Z. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.001 · Cited by 44
Chlebowski, R. T., Barrington, W. E., Aragaki, A. K., Manson, J. E., Sarto, G. E., O’Sullivan, M. J., Wu, D. Y., Cauley, J. A., Qi, L., Wallace, R. B., et al. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000733 · Cited by 44
Self-citationVermeulen, R. F. M., Korse, C. M., Kenter, G. G., Zanten, M. M. A. B.-V., & van Beurden, M. (2019) · Climacteric · doi:10.1080/13697137.2019.1582622 · Cited by 38
Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials
Mirkin, S., Pinkerton, J. V., Kagan, R., Thompson, J. R., Pan, K., Pickar, J. H., Komm, B. S., & Archer, D. F. (2016) · Journal of Women s Health · doi:10.1089/jwh.2015.5351 · Cited by 35
Riemma, G., Schiattarella, A., Verde, M. L., Zarobbi, G., Garzon, S., Cucinella, G., Calagna, G., Labriola, D., & FRANCISCIS, P. D. (2019) · Medicina · doi:10.3390/medicina55090554 · Cited by 35
Gabapentin for the treatment of hot flushes in menopause: a meta-analysis
Yoon, S.-H., Lee, J. Y., Lee, C., Lee, H., & Kim, S.-N. (2020) · Menopause · doi:10.1097/gme.0000000000001491 · Cited by 35
Current recommendations: what is the clinician to do?
Manson, J. E. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.043 · Cited by 31
Self-citationKe, Y., Labrie, F., Gonthier, R., Simard, J.-N., Bergeron, D., Martel, C., Vaillancourt, M., Montesino, M., Lavoie, L., Archer, D. F., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.08.016 · Cited by 30
Hormone Replacement Therapy, Family History, and Breast Cancer Risk Among Postmenopausal Women
Gramling, R. E., Eaton, C. B., Rothman, K. J., Cabral, H., Silliman, R. A., & Lash, T. L. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a71279 · Cited by 22
Comparison of gabapentin with estrogen for treatment of hot flashes in post-menopausal women
Rouholamin, S., Valaie, S., & Allameh, Z. S. (2013) · Journal of Research in Pharmacy Practice · doi:10.4103/2279-042x.117392 · Cited by 19
Pharmacotherapeutic options for the treatment of menopausal symptoms
Genazzani, A. R., Monteleone, P., Giannini, A., & Simoncini, T. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1921148 · Cited by 10
Cited by
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 360
Metadata
- Authors
- Crandall, C. J., Mehta, J. M., & Manson, J. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2023-02-07
- Volume
- 329
- Issue
- 5
- Pages
- 405
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4319334031
- Cited by
- 316
- References
- 113
- FWCI
- 52.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.